Remarkably, high CD19 expression was significantly correlated with improved disease-free survival (based on fresh-frozen tumor tissue samples obtained from an additional cervical cancer patient cohort), whereas CD3E, CD20 and TCL1A were not significantly correlated with survival. Here, MS4A1 is linked to cervical cancer.